PDS Biotechnology Corporation
NASDAQ:PDSB · NASDAQ Capital Market
-$0.07 today
Vol 0.48M · Avg 1.02M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-42.31%
Period High
$1.62
Period Low
$0.54
Latest
$0.93
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
OnKure Therapeutics, Inc.
NASDAQ:OKUR
$57.43M
Xilio Therapeutics, Inc.
NASDAQ:XLO
$54.64M
Kezar Life Sciences, Inc.
KZR
$53.86M
LAVA Therapeutics N.V.
LVTX
$45.77M
FibroGen, Inc.
FGEN
$36.69M
Annovis Bio, Inc.
ANVS
$35.02M
INmune Bio, Inc.
INMB
$32.97M
Actinium Pharmaceuticals, Inc.
ATNM
$31.69M
Tempest Therapeutics, Inc.
TPST
$5.60M
Reviva Pharmaceuticals Holdings, Inc.
RVPH
$2.33M
What is the latest PDSB filing?
The latest filing shown is 8-K dated Jun 2, 2026.
How many recent filings does PDSB have?
Intrinsic Alpha currently shows 20 recent filings for PDSB.
Explore More
Continue the stock analysis
Jump to another research area for this company.